{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:05:37Z","timestamp":1760267137651},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2011,11,15]],"date-time":"2011-11-15T00:00:00Z","timestamp":1321315200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s00296-011-2224-0","type":"journal-article","created":{"date-parts":[[2011,11,14]],"date-time":"2011-11-14T08:10:29Z","timestamp":1321258229000},"page":"3531-3536","source":"Crossref","is-referenced-by-count":19,"title":["Anti-cyclic citrullinated peptide antibodies and rheumatoid factor sera titers in leprosy patients from Mexico"],"prefix":"10.1007","volume":"32","author":[{"given":"Mar\u00eda G.","family":"Zavala-Cerna","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Fafutis-Morris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Guillen-Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Salazar-P\u00e1ramo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana E.","family":"Garc\u00eda-Cruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Riebeling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnulfo","family":"Nava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,11,15]]},"reference":[{"issue":"9416","key":"2224_CR1","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/S0140-6736(04)15952-7","volume":"363","author":"WJ Britton","year":"2004","unstructured":"Britton WJ, Lockwood DN (2004) Leprosy. Lancet 363(9416):1209\u20131219","journal-title":"Lancet"},{"issue":"5","key":"2224_CR2","first-page":"904","volume":"20","author":"T Kamradt","year":"1993","unstructured":"Kamradt T (1993) T cell unresponsiveness in lepromatous leprosy. J Rheumatol 20(5):904\u2013906","journal-title":"J Rheumatol"},{"issue":"4","key":"2224_CR3","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.4049\/jimmunol.149.4.1470","volume":"149","author":"M Yamamura","year":"1992","unstructured":"Yamamura M et al (1992) Cytokine patterns of immunologically mediated tissue damage. J Immunol 149(4):1470\u20131475","journal-title":"J Immunol"},{"issue":"3","key":"2224_CR4","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/rheumatology\/37.3.270","volume":"37","author":"F Medina","year":"1998","unstructured":"Medina F et al (1998) Anti-neutrophil cytoplasmic autoantibodies in leprosy. Br J Rheumatol 37(3):270\u2013273","journal-title":"Br J Rheumatol"},{"key":"2224_CR5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/03009748809096783","volume":"75","author":"M Harboe","year":"1988","unstructured":"Harboe M (1988) Rheumatoid factors in leprosy and parasitic diseases. Scand J Rheumatol Suppl 75:309\u2013313","journal-title":"Scand J Rheumatol Suppl"},{"issue":"5","key":"2224_CR6","first-page":"900","volume":"20","author":"I Garcia-De La Torre","year":"1993","unstructured":"Garcia-De La Torre I (1993) Autoimmune phenomena in leprosy, particularly antinuclear antibodies and rheumatoid factor. J Rheumatol 20(5):900\u2013903","journal-title":"J Rheumatol"},{"issue":"2","key":"2224_CR7","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s10067-006-0281-7","volume":"26","author":"FL Edington","year":"2007","unstructured":"Edington FL et al (2007) Anti-neutrophil cytoplasmic antibodies in leprosy. Clin Rheumatol 26(2):208\u2013210","journal-title":"Clin Rheumatol"},{"issue":"2","key":"2224_CR8","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1128\/IAI.66.2.499-504.1998","volume":"66","author":"AH Zea","year":"1998","unstructured":"Zea AH et al (1998) Changes in expression of signal transduction proteins in T lymphocytes of patients with leprosy. Infect Immun 66(2):499\u2013504","journal-title":"Infect Immun"},{"issue":"5029","key":"2224_CR9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1126\/science.1925582","volume":"254","author":"M Yamamura","year":"1991","unstructured":"Yamamura M et al (1991) Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 254(5029):277\u2013279","journal-title":"Science"},{"issue":"1","key":"2224_CR10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1055\/s-2004-822305","volume":"25","author":"CM Mason","year":"2004","unstructured":"Mason CM, Ali J (2004) Immunity against mycobacteria. Semin Respir Crit Care Med 25(1):53\u201361","journal-title":"Semin Respir Crit Care Med"},{"issue":"1","key":"2224_CR11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1574-695X.2001.tb01586.x","volume":"31","author":"TJ Kang","year":"2001","unstructured":"Kang TJ, Chae GT (2001) Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients. FEMS Immunol Med Microbiol 31(1):53\u201358","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"7","key":"2224_CR12","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.4049\/jimmunol.170.7.3451","volume":"170","author":"PY Bochud","year":"2003","unstructured":"Bochud PY, Hawn TR, Aderem A (2003) Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling. J Immunol 170(7):3451\u20133454","journal-title":"J Immunol"},{"issue":"4","key":"2224_CR13","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1365-2567.2004.01926.x","volume":"112","author":"TJ Kang","year":"2004","unstructured":"Kang TJ et al (2004) Differential production of interleukin-10 and interleukin-12 in mononuclear cells from leprosy patients with a Toll-like receptor 2 mutation. Immunology 112(4):674\u2013680","journal-title":"Immunology"},{"issue":"2","key":"2224_CR14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0190-9622(83)70021-6","volume":"8","author":"RL Modlin","year":"1983","unstructured":"Modlin RL et al (1983) T lymphocyte subsets in the skin lesions of patients with leprosy. J Am Acad Dermatol 8(2):182\u2013189","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"2224_CR15","doi-asserted-by":"crossref","first-page":"i","DOI":"10.4049\/jimmunol.137.1.i.i","volume":"137","author":"BR Bloom","year":"1986","unstructured":"Bloom BR (1986) Learning from leprosy: a perspective on immunology and the Third World. J Immunol 137(1):i\u2013x","journal-title":"J Immunol"},{"issue":"3","key":"2224_CR16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1055\/s-2004-829500","volume":"25","author":"JM Grange","year":"2004","unstructured":"Grange JM, Lethaby JI (2004) Leprosy of the past and today. Semin Respir Crit Care Med 25(3):271\u2013281","journal-title":"Semin Respir Crit Care Med"},{"issue":"8","key":"2224_CR17","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1172\/JCI34189","volume":"118","author":"D Cruz","year":"2008","unstructured":"Cruz D et al (2008) Host-derived oxidized phospholipids and HDL regulate innate immunity in human leprosy. J Clin Invest 118(8):2917\u20132928","journal-title":"J Clin Invest"},{"issue":"7","key":"2224_CR18","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.humpath.2006.12.017","volume":"38","author":"AM Iyer","year":"2007","unstructured":"Iyer AM et al (2007) Leprosy-specific B-cells within cellular infiltrates in active leprosy lesions. Hum Pathol 38(7):1065\u20131073","journal-title":"Hum Pathol"},{"issue":"1","key":"2224_CR19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/rheumatology\/kei111","volume":"45","author":"AJ Zendman","year":"2006","unstructured":"Zendman AJ, van Venrooij WJ, Pruijn GJ (2006) Use and significance of anti-CCP autoantibodies in rheumatoid arthritis. Rheumatology (Oxford) 45(1):20\u201325","journal-title":"Rheumatology (Oxford)"},{"key":"2224_CR20","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00296-008-0535-6","volume":"28","author":"MG Zavala-Cerna","year":"2008","unstructured":"Zavala-Cerna MG et al (2008) Serum IgG activity against cyclic citrullinated peptide in patients evaluated for rheumatoid factor correlates with the IgM isotype. Rheumatol Int 28:851\u2013857","journal-title":"Rheumatol Int"},{"issue":"8","key":"2224_CR21","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1136\/ard.2005.045229","volume":"65","author":"O Elkayam","year":"2006","unstructured":"Elkayam O et al (2006) Positive anti-cyclic citrullinated proteins and rheumatoid factor during active lung tuberculosis. Ann Rheum Dis 65(8):1110\u20131112","journal-title":"Ann Rheum Dis"},{"key":"2224_CR22","first-page":"69","volume":"36","author":"WH Jopling","year":"1965","unstructured":"Jopling WH (1965) Basic principles in carrying out a pilot therapeutic trial in leprosy. Lepr Rev 36:69\u201371","journal-title":"Lepr Rev"},{"issue":"4","key":"2224_CR23","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s10067-007-0810-z","volume":"27","author":"LS Guedes-Barbosa","year":"2008","unstructured":"Guedes-Barbosa LS, Mangueira C, Scheinberg M (2008) Anticitrulline peptide antibodies (CCP3) in leprosy sera: a negative association. Clin Rheumatol 27(4):515\u2013516","journal-title":"Clin Rheumatol"},{"issue":"11","key":"2224_CR24","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1590\/S0100-879X2008001100010","volume":"41","author":"SL Ribeiro","year":"2008","unstructured":"Ribeiro SL et al (2008) Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in leprosy patients with articular involvement. Braz J Med Biol Res 41(11):1005\u20131010","journal-title":"Braz J Med Biol Res"},{"issue":"7818","key":"2224_CR25","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/S0140-6736(73)91816-3","volume":"1","author":"B Petchclai","year":"1973","unstructured":"Petchclai B et al (1973) Autoantibodies in leprosy among Thai patients. Lancet 1(7818):1481\u20131482","journal-title":"Lancet"},{"issue":"1","key":"2224_CR26","first-page":"108","volume":"14","author":"RA Miller","year":"1987","unstructured":"Miller RA et al (1987) The limited spectrum of antinuclear antibodies in leprosy. J Rheumatol 14(1):108\u2013110","journal-title":"J Rheumatol"},{"issue":"4","key":"2224_CR27","first-page":"738","volume":"12","author":"M Chavez-Legaspi","year":"1985","unstructured":"Chavez-Legaspi M, Gomez-Vazquez A, Garcia-De La Torre I (1985) Study of rheumatic manifestations and serologic abnormalities in patients with lepromatous leprosy. J Rheumatol 12(4):738\u2013741","journal-title":"J Rheumatol"},{"issue":"1","key":"2224_CR28","doi-asserted-by":"crossref","first-page":"50","DOI":"10.47276\/lr.75.1.50","volume":"75","author":"V Pradhan","year":"2004","unstructured":"Pradhan V, Badakere SS, Shankar Kumar U (2004) Increased incidence of cytoplasmic ANCA (cANCA) and other autoantibodies in leprosy patients from western India. Lepr Rev 75(1):50\u201356","journal-title":"Lepr Rev"},{"issue":"2","key":"2224_CR29","first-page":"76","volume":"70","author":"K Vengadakrishnan","year":"2004","unstructured":"Vengadakrishnan K, Saraswat PK, Mathur PC (2004) A study of rheumatological manifestations of leprosy. Indian J Dermatol Venereol Leprol 70(2):76\u201378","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"2224_CR30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10067-005-1147-0","volume":"25","author":"HA Al-Raqum","year":"2006","unstructured":"Al-Raqum HA et al (2006) First report of leprosy presenting as acute polyarthritis in the setting of type I downgrading lepra reaction. Clin Rheumatol 25(1):101\u2013105","journal-title":"Clin Rheumatol"},{"key":"2224_CR31","doi-asserted-by":"crossref","unstructured":"Belgaumkar VA, Gokhale NR, Mahajan PM, Bharadwaj R, Pandit DP, Deshpande S (2007) Circulating cytokine profiles in leprosy patients. Lepr Rev 78(3):223\u2013230 (PubMed PMID: 18035773)","DOI":"10.47276\/lr.78.3.223"},{"key":"2224_CR32","doi-asserted-by":"crossref","unstructured":"Lockwood DN, Sarno E, Smith WC (2007) Classifying leprosy patients\u2013searching for the perfect solution? Lepr Rev 78(4):317\u2013320 (PubMed PMID: 18309704)","DOI":"10.47276\/lr.78.4.317"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2224-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-011-2224-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-011-2224-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,11]],"date-time":"2023-06-11T03:25:38Z","timestamp":1686453938000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-011-2224-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,15]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["2224"],"URL":"https:\/\/doi.org\/10.1007\/s00296-011-2224-0","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,15]]}}}